蝨子治療市場：按產品類型、按分銷管道、按地區：規模、份額、前景、機會分析，2023-2030 年

到 2023 年，全球蝨子治療市場估計為 10.498 億美元，預計在預測期內（2023-2030 年）複合年增長率為 6%。

蝨子是寄生在人的頭部和身體（包括生殖器）上的昆蟲。感染人類的蝨子有三種類型：體蝨、頭蝨和生殖器蝨子。蝨子是一種無翅的小昆蟲，以人類血液為食。蝨子透過密切接觸和共用物品在人與人之間傳播。如果沒有適當的治療，這種情況可能會復發。蝨子治療產品可透過非處方藥 (OTC) 或處方購買。這些產品將有助於去除蝨子。頭蝨僅靠人類血液生存生長，一旦脫離人類宿主，幾小時內就會餓死。另一方面，一旦蝨子（頭蝨卵）與人類宿主分離，它們通常會在一周內死亡。雖然頭蝨感染確實會造成不便和不愉快，但它們通常是無害的。

市場動態

蝨子盛行率的增加、蝨子治療產品的容易獲得以及人們意識的提高是預計在預測期內有助於全球蝨子治療市場成長的一些關鍵因素。2020 年 10 月，美國食品藥物管理局 (FDA) 透過名為 Rx-Over-the-Counter (OTC) Switch 的流程批准了非處方或非處方 (OTC) 的頭蝨治療乳液..2012年2月，美國FDA核准0.5% Sklice（伊維菌素）洗劑作為處方藥，用於治療6個月及以上兒童的頭蝨。

本研究的主要特點

• 本報告對全球蝨子治療市場進行了詳細分析，並介紹了以2022年為基準年的預測期（2023-2030）的市場規模和復合年增長率（CAGR）。
• 它還闡明了各個細分市場的潛在收入機會，並解釋了該市場有吸引力的投資主張矩陣。
• 它還提供了有關市場驅動因素、限制因素、機會、新產品發布和批准、市場趨勢、區域前景、主要參與者採取的競爭策略等的重要見解。
• 它根據公司亮點、產品組合、主要亮點、財務表現和策略等參數，介紹了全球蝨子治療市場的主要參與者。
• 本研究涵蓋的主要公司包括 Fleming Medical Ltd、ParaPRO, LLC、Prestige Consumer Healthcare Inc.、Omega Pharma（Perrigo Company plc 的子公司）、Alliance Pharma PLC、Oystershell、Johnson & Johnson Private Limited、GSK plc 和 Arbor Pharmaceuticals Inc .（Azurity Pharmaceuticals, Inc. 的子公司）。
• 該報告的見解將使行銷人員和公司高管能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
• 全球蝨子治療市場報告迎合了該行業的各種利益相關者，如投資者、供應商、產品製造商、分銷商、新進業者和財務分析師。
• 利害關係人可以透過用於分析全球蝨子治療市場的各種策略矩陣來促進他們的決策。

目錄

第一章 研究目的與前提

• 研究目標
• 先決條件
• 縮略語

第二章 市場概況

• 報告摘要
  • 市場定義和範圍
• 執行摘要
• 連貫的機會地圖 (COM)

第三章 市場動態、法規與趨勢分析

• 市場動態
  • 促進者
  • 抑製劑
  • 市場機會
  • 影響分析
  • 近期產品發布
  • 流行病學
  • 合併、收購、聯盟
  • 監管場景
  • 重大發展
  • PEST分析

第四章全球蝨子治療市場 - COVID-19 影響分析

• 經濟影響
• COVID-19 流行病學
• 對供需的影響

第五章全球蝨子治療市場：依產品類型，2018-2030

• 非處方藥物
• 氯菊酯
• 除蟲菊酯
• 其他產品類型
• 處方藥
• 伊維菌素
• 多殺菌素
• 馬拉硫磷
• 其他處方藥

第六章全球蝨子治療市場：依分銷管道劃分，2018-2030

• 醫院和診所
• 零售藥店
• 其他分銷渠道

第七章 全球蝨子治療市場：依地區劃分，2018-2030

• 北美
• 美國
• 加拿大
• 拉丁美洲
• 巴西
• 墨西哥
• 阿根廷
• 其他拉丁美洲
• 歐洲
• 英國
• 德國
• 意大利
• 法國
• 西班牙
• 俄羅斯
• 歐洲其他地區
• 亞太地區
• 中國
• 印度
• 日本
• 東盟
• 澳大利亞
• 韓國
• 亞太其他地區
• 中東
• 海灣合作委員會
• 以色列
• 其他中東
• 非洲
• 北非
• 中部非洲
• 南非
• 世界其他地區

第八章 競爭格局

• Fleming Medical Ltd
• ParaPRO, LLC
• Prestige Consumer Healthcare Inc.
• Omega Pharma（A subsidiary of Perrigo Company plc）
• Alliance Pharma PLC
• Oystershell
• Johnson & Johnson Private Limited
• GSK plc
• Arbor Pharmaceuticals Inc.（A subsidiary of Azurity Pharmaceuticals, Inc.）

第9章 章節

• 調查方法
• 關於出版商

The global lice treatment market is estimated to be valued at US$ 1,049.8 Mn in 2023 and is expected to exhibit a CAGR of 6% during the forecast period (2023-2030).

Lice are parasitic insects that can be found on people's heads and bodies, including the pubic area. There are three types of lice that affect humans: body lice, head lice, and pubic lice. Lice are tiny, wingless insects that feed on human blood. Lice spread from person to person through close contact and by sharing belongings. Unless treated properly, this condition can become a recurring problem. Lice treatment products are available over-the-counter (OTC) and/or with a prescription. These products help eliminate lice. Head lice survive and thrive solely on human blood, once they're separated from the human host, they starve and perish within several hours. Nits (head lice eggs), on the other hand, generally die within a week of being released from their human host. While it's true that an infestation of head lice is inconvenient and perhaps uncomfortable, it's usually harmless.

Market Dynamics

Increasing prevalence of lice infestation, easy availability of lice treatment products, and a rise in awareness among people are some major factors expected to aid in the growth of the global lice treatment market during the forecast period. In October 2020, the U.S. Food and Drug Administration (FDA) approved a lotion to treat head lice for nonprescription, or over-the-counter (OTC), use through a process called a prescription (Rx)-to-OTC switch. The U.S. FDA initially approved Sklice (ivermectin) lotion, 0.5% for the treatment of head lice in patients 6 months of age and older as a prescription drug in February 2012.

Key features of the study:

• This report provides an in-depth analysis of the global lice treatment market and provides market size (US$ Mn) and compound annual growth rate (CAGR) for the forecast period (2023-2030), considering 2022 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global lice treatment market based on the following parameters- company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Fleming Medical Ltd, ParaPRO, LLC, Prestige Consumer Healthcare Inc., Omega Pharma (A subsidiary of Perrigo Company plc), Alliance Pharma PLC, Oystershell, Johnson & Johnson Private Limited, GSK plc, and Arbor Pharmaceuticals Inc. (A subsidiary of Azurity Pharmaceuticals, Inc.)
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• Global lice treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global lice treatment market.

Detailed Segmentation:

• Global Lice Treatment Market, By Product Type:
  • OTC Medication
  • Permethrin
  • Pyrethrin
  • Other Product Types
  • Prescription Medication
  • Ivermectin
  • Spinosad
  • Malathion
  • Other Prescription Medications
• Global Lice Treatment Market, By Distribution Channel:
  • Hospitals And Clinics
  • Retail Pharmacies
  • Other Distribution Channels
• Global Lice Treatment Market, By Geography:
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
  • South Africa
  • Central Africa
  • North Africa
• Company Profiles
  • Fleming Medical Ltd
  • ParaPRO, LLC
  • Prestige Consumer Healthcare Inc.
  • Omega Pharma (A subsidiary of Perrigo Company plc)
  • Alliance Pharma PLC
  • Oystershell
  • Johnson & Johnson Private Limited
  • GSK plc
  • Arbor Pharmaceuticals Inc. (A subsidiary of Azurity Pharmaceuticals, Inc.)

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Product Type
  • Market Snapshot, By Distribution Channel
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
  • Impact Analysis
  • Recent Product Launches
  • Epidemiology
  • Merger, Acquisition, and Collaborations
  • Regulatory Scenario
  • Key Developments
  • PEST Analysis

4. Global Lice Treatment Market- COVID-19 Impact Analysis

• Economic Impact
• COVID-19 Epidemiology
• Impact on Supply and Demand

5. Global Lice Treatment Market, By Product Type, 2018-2030, (US$ Mn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2018-2030
  • Segment Trends
• OTC Medication
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
• Permethrin
• Pyrethrin
• Other Product Types
• Prescription Medication
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
• Ivermectin
• Spinosad
• Malathion
• Other Prescription Medications

6. Global Lice Treatment Market, By Distribution Channel, 2018-2030, (US$ Mn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2018-2030
  • Segment Trends
• Hospitals and Clinics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
• Retail Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
• Other Distribution Channels
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)

7. Global Lice Treatment Market, By Region, 2018-2030, (US$ Mn)

• Introduction
  • Market Share Analysis, By Region, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, For Regions, 2018-2030
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Drug type, 2018-2030, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018- 2030, (US$ Mn)
• U.S.
• Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Drug type, 2018-2030, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018- 2030, (US$ Mn)
• Brazil
• Mexico
• Argentina
• Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Drug type, 2018-2030, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Mn)
• U.K.
• Germany
• Italy
• France
• Spain
• Russia
• Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Drug type, 2018-2030, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Mn)
• China
• India
• Japan
• ASEAN
• Australia
• South Korea
• Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Drug type, 2018-2030, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018- 2030, (US$ Mn)
• GCC
• Israel
• Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Drug type, 2018-2030, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Mn)
• North Africa
• Central Africa
• South Africa
• Rest Of The World
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Drug type, 2018-2030, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Mn)

8. Competitive Landscape

• Fleming Medical Ltd
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• ParaPRO, LLC
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Prestige Consumer Healthcare Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Omega Pharma (A subsidiary of Perrigo Company plc)
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Alliance Pharma PLC
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Oystershell
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Johnson & Johnson Private Limited
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• GSK plc
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Arbor Pharmaceuticals Inc. (A subsidiary of Azurity Pharmaceuticals, Inc.)
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies

9. Section

• Research Methodology
• About Us